2023 Subspecialty Focused Meeting (ON-DEMAND)

2023 Subspecialty Focused Meeting (ON-DEMAND)

  • Register
    • Non-member - $725
    • Member - $525
    • Resident/Fellow - $325
    • Student - Free!

2023 Subspecialty Focused Meeting (On-Demand)

Advance your knowledge of the most updated clinical practice standards of care in cardiology, pulmonology, critical care, infectious diseases, gastroenterology, and endocrinology.

19.00 hours of AOA Category 1A credits and AMA PRA Category 1 Credits™.

Note: ACOI reports credits to the AOA after the end of each quarter. 

What You’ll Learn

  • Expand your knowledge in multiple specialty areas.
  • Stay ahead of the curve on seasonal viruses, health screenings, and vaccines.
  • Hear about breakthrough procedures in gastroenterology and pulmonary hypertension.
  • Learn about new POCUS and OMM Updates.
  • Contains 5 Component(s), Includes Credits

    CME Credit Available: This activity offers .5 1A AOA Note: ACOI reports credits to the AOA at the end of each quarter. Learning Objectives: In this session, you'll learn how to: • Review basic Osteopathic philosophy, physiology and the application of OMT • Review OMT techniques that subspecialists can utilize safely for patients • Review how these techniques can be easily become adjuncts to our standard medical care to improve patient outcomes

    CME Credit Available: This activity offers 0.5 1A AOA 

    Note: ACOI reports credits to the AOA at the end of each quarter.

    Learning Objectives: 

    In this session, you'll learn how to:

    • Review basic Osteopathic philosophy, physiology and the application of OMT
    • Review OMT techniques that subspecialists can utilize safely for patients 
    • Review how these techniques can be easily become adjuncts to our standard medical care to improve patient outcomes

    Conflict of Interest Disclosures: 

     ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Dr. Tsompanidis, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

    Release & Review Date: 

     This activity is valid from May 13, 2023, until May 13, 2026. 

    Antonios J. Tsompanidis, DO

    Chief Academic Officer

    CarePoint Health

    Chief Academic Officer
    CarePoint Health Christ Hospital, Jersey City
    CarePoint Health Bayonne Medical Center, Bayonne
    New Jersey

  • Contains 5 Component(s), Includes Credits

    CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: In this session, you'll learn how to: • Be able to define the 'tripledemic' • Comprehend immunity debt • Recognize the importance of RSV vaccine and its target the F-protein • Appreciate the new COVID variants including an Omicron sub variant XBC. 1.6 that is a recombination of both Delta and Omicron variants

    CME Credit Available: 

    This activity offers .75 1A AOA

    Note: ACOI reports credits to the AOA after the end of each quarter. 

    Learning Objectives: 

    In this session, you'll learn how to:

    • Be able to define the 'tripledemic'
    • Comprehend immunity debt
    • Recognize the importance of RSV vaccine and its target the F-protein
    • Appreciate the new COVID variants including an Omicron sub variant XBC. 1.6 that is a recombination of both Delta and Omicron variants

    Conflict of Interest Disclosures: 

     ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Dr. Dery, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

    Release & Review Date: 

    This activity is valid from May 13, 2023, until May 13, 2026.

    MarkAlain Dery, DO, MPH, FACOI

    Chief Innovation Officer

    Access Health Louisiana

    Chief Innovation Officer
    Access Health Louisiana

    Adjunct Professor of Medicine
    Tulane University School of Medicine

    ACOI Board of Directors Member

  • Contains 5 Component(s), Includes Credits

    CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: In this session, you'll learn how to: • Compare and contrast the 4 main endemic fungal infections • Analyze geographical and environmental implications of these infections when considering treatment and prevention interventions. • Understand when treatment is necessary and working with ID specialists to manage long term treatment therapies

    CME Credit Available:

    This activity offers .75 1A AOA 

    Note: ACOI reports credits to the AOA after the end of each quarter.

    Learning Objectives: 

    In this session, you'll learn how to:

    • Compare and contrast the 4 main endemic fungal infections
    • Analyze geographical and environmental implications of these infections when considering treatment and prevention interventions
    • Understand when treatment is necessary and working with ID specialists to manage long term treatment therapies

    Conflict of Interest Disclosures: 

    ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Dr. Dery, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

    Release & Review Date: 

     This activity is valid from May 13, 2023, until May 13, 2026.

    MarkAlain Dery, DO, MPH, FACOI

    Chief Innovation Officer

    Access Health Louisiana

    Chief Innovation Officer
    Access Health Louisiana

    Adjunct Professor of Medicine
    Tulane University School of Medicine

    ACOI Board of Directors Member

  • Contains 5 Component(s), Includes Credits

    CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: In this session, you'll learn how to: • Decrease administrative burden • Decrease the need for audits • Decrease unnecessary documentation in the medical record • Ensure that payment for E/M is resource based and that there is no direct goal for payment redistribution between specialties

    CME Credit Available:

    This activity offers .75 1A AOA 

    Note: ACOI reports credits to the AOA after the end of each quarter.

    Learning Objectives: 

    In this session, you'll learn how to:

    • Decrease administrative burden
    • Decrease the need for audits
    • Decrease unnecessary documentation in the medical record
    • Ensure that payment for E/M is resource based and that there is no direct goal for payment redistribution between specialties

    Conflict of Interest Disclosures: 

    ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Dr. Young, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

    Release & Review Date: 

    This activity is valid from May 13, 2023, until May 13, 2026.

    Jill M. Young, CPC, CEDC, CIMC

    Principal Consultant

    Young Medical Consulting, LLC

    Young Medical Consulting, LLC, East Lansing, MI

  • Contains 5 Component(s), Includes Credits

    CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: In this session, you'll learn how to: • Definition of cancer therapy–related cardiac dysfunction (CTRCD) • Role of imaging in the management of CTRCD • Review recent guidelines and pragmatic approach to managing cardio-oncology patients

    CME Credit Available: 

    This activity offers .75 1A AOA 

    Note: ACOI reports credits to the AOA after the end of each quarter.

    Learning Objectives:

    In this session, you'll learn how to:  

    • Definition of cancer therapy–related cardiac dysfunction (CTRCD)
    • Role of imaging in the management of CTRCD
    • Review recent guidelines and pragmatic approach to managing cardio-oncology patients

    Conflict of Interest Disclosures: 

    ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Dr. Gongidi, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

    Release & Review Date: 

    This activity is valid from May 13, 2023, until May 13, 2026.

    Vikranth Gongidi, DO, FACOI

    Cardiologist

    Cleveland Clinic Indian River Medical Center

    Director of Cardiology
    Cardiologist
    Cleveland Clinic Indian River Medical Center
    Vero Beach, FL

  • Contains 5 Component(s), Includes Credits

    CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: In this session, you'll learn how to: • Define the recommendations for use of Novel Oral Anticoagulants (NOACs) for treatment of Atrial Fibrillation and exclusion criteria for their use based upon the 2019 ACC/AHA/HRS Focused Update of Treatment Guidelines to Prevent Thromboembolism in Patients with Atrial Fibrillation. • Discuss the research literature that led to the Centers for Medicare Services (CMS) to adopt the National Coverage Decision for Left Atrial Appendage Occluder Device Implant and review the specific criteria that must be met for a patient to be considered eligible to receive a Left Atrial Appendage Occluder Device. • Discuss the up-to-date literature that compares Left Atrial Appendage Occlusion, Direct Oral Anticoagulants and Warfarin usage for patients with Nonvalvular Atrial Fibrillation

    CME Credit Available:

    This activity offers .75 1A AOA 

    Note: ACOI reports credits to the AOA after the end of each quarter.

    Learning Objectives:

    In this session, you'll learn how to:  

    • Define the recommendations for use of Novel Oral Anticoagulants (NOACs) for treatment of Atrial Fibrillation and exclusion criteria for their use based upon the 2019 ACC/AHA/HRS Focused Update of Treatment Guidelines to Prevent Thromboembolism in Patients with Atrial Fibrillation.
    • Discuss the research literature that led to the Centers for Medicare Services (CMS) to adopt the National Coverage Decision for Left Atrial Appendage Occluder Device Implant and review the specific criteria that must be met for a patient to be considered eligible to receive a Left Atrial Appendage Occluder Device.
    • Discuss the up-to-date literature that compares Left Atrial Appendage Occlusion, Direct Oral Anticoagulants and Warfarin usage for patients with Nonvalvular Atrial Fibrillation

    Conflict of Interest Disclosures: 

    ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Dr. Faulknier, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

    Release & Review Date: 

    This activity is valid from May 13, 2023, until May 13, 2026.

    Brett Faulknier, DO

    Section Chair, Electrophysiology

    Cleveland Clinic Indian River Hospital

    Assistant Clinical Professor of Medicine - VCOM, Edward Via College of Osteopathic Medicine
    Section Chair, Electrophysiology, Cleveland Clinic Indian River Hospital, Vero Beach, Florida

  • Contains 5 Component(s), Includes Credits

    CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: In this session, you'll learn how to: • Discuss the pathology of tricuspsid regurgitation including CIED (cardiac implantable electronic device) related tricuspid regurgitation. • Review current assessment recommendations with echocardiography for severe tricuspid regurgitation and tricuspid valve disease. • Discuss current and upcoming options for repair and replacement for severe tricuspid regurgitation.

    CME Credit Available:

    This activity offers .75 1A AOA 

    Note: ACOI reports credits to the AOA after the end of each quarter.

    Learning Objectives:

    In this session, you'll learn how to:

    • Discuss the pathology of tricuspid regurgitation including CIED (cardiac implantable electronic device) related tricuspid regurgitation.
    • Review current assessment recommendations with echocardiography for severe tricuspid regurgitation and tricuspid valve disease.
    • Discuss current and upcoming options for repair and replacement for severe tricuspid regurgitation.

    Conflict of Interest Disclosures: 

    ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Dr. Sullivan, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

    Release & Review Date: 

    This activity is valid from May 13, 2023, until May 13, 2026.

    Laura Sullivan, MD

    Echo Lab Director

    Cleveland Clinic Indian River Hospital

    Echo Lab Director
    Cleveland Clinic Indian River Hospital

  • Contains 5 Component(s), Includes Credits

    CME Credit Available: This activity offers 1.5 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: In this session, you'll learn how to: • To increase our Osteopathic Internists thoughtfulness, compassion, knowledgeable, and overall unique capabilities • To (hopefully) provide “pearls” useful to the internist in the care of his/her patients with complex or otherwise challenging medical problems • In the appropriate scenario, to remind clinicians to consider Toxic Shock Syndrome, potentially resulting in an improved outcome where current mortality estimates are 30-70%

    CME Credit Available:

    This activity offers 1.5 1A AOA 

    Note: ACOI reports credits to the AOA after the end of each quarter.

    Learning Objectives:

    In this session, you'll learn:

    • To increase our Osteopathic Internists thoughtfulness, compassion, knowledgeable, and overall unique capabilities
    • To (hopefully) provide “pearls” useful to the internist in the care of his/her patients with complex or otherwise challenging medical problems
    • In the appropriate scenario, to remind clinicians to consider Toxic Shock Syndrome, potentially resulting in an improved outcome where current mortality estimates are 30-70%

    Conflict of Interest Disclosures: 

    ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Drs. Blackburn, Hubbard, Kaiser-Smith, LePane, and Prior, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

    Release & Review Date: 

    This activity is valid from May 13, 2023, until May 13, 2026.

    Gerald W. Blackburn, DO, MACOI (Moderator)

    Clinical Professor of Medicine

    Michigan State University, College of Osteopathic Medicine

    Teaching Faculty, Section of Infectious Disease, Corewell Health/Botsford Campus
    Farmington Hills, MI

    Clinical Professor of Medicine
    Michigan State University
    College of Osteopathic Medicine

    Kevin P. Hubbard, DO, MACOI

    Clinical Professor of Medicine

    University of Missouri - Kansas City School of Medicine

    Director, Palliative Medicine Service
    Associate Hospice Medical Director
    Saint Luke’s Health System

    Clinical Professor of Medicine
    The University of Missouri-Kansas City School of Medicine

    Joanne Kaiser-Smith, DO, FACOI (President)

    Associate Dean

    Associate Dean for Graduate Medical Education and Professor of Medicine at RowanSOM

    Professor of Medicine at RowanSOM

    Stratford, New Jersey

    Charlene A. LePane, DO, FACOI

    Gastroenterologist

    AdventHealth

    Executive Director, AdventHealth Medical Group Medicine Specialties

    Asst. Chief of Staff, AdventHealth, Celebration, Florida

    Voluntary Adjunct Faculty, NSUKPCOM, KCUCOM, UCF College of Medicine, LECOM

    John E. Prior, DO, FACOI

    Clinical Associate Professor of Medicine

    The Geisinger Commonwealth School of Medicine

    Clinical Associate Professor of Medicine
    The Geisinger Commonwealth School of Medicine
    Scranton, Pa

  • Contains 5 Component(s), Includes Credits

    CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: In this session, you'll learn how to: • Sleep apnea is a common medical condition, and all patients should be at least screened for the risk factors. • Testing can be done easily in the outpatient setting for sleep apnea. • Monitoring compliance to assure adequate treatment is needed.

    CME Credit Available:

    This activity offers .75 1A AOA 

    Note: ACOI reports credits to the AOA after the end of each quarter.

    Learning Objectives:

    In this session, you'll learn:

    • Sleep apnea is a common medical condition, and all patients should be at least screened for the risk factors.
    • Testing can be done easily in the outpatient setting for sleep apnea.
    • Monitoring compliance to assure adequate treatment is needed.

    Conflict of Interest Disclosures: 

    ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Dr. Zetoony Nudell, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

    Release & Review Date: 

    This activity is valid from May 13, 2023, until May 13, 2026.

    Michelle F. Zetoony-Nudell, DO, FACOI

    Clinician and Owner

    DO Sleep Solutions, Inc

    Teaching Faculty, NOVA Southeastern School of Osteopathic Medicine
    Teaching Faculty, PA-USF Morsani School of Medicine
    Clinician and Owner, DO Sleep Solutions, Inc.
    Pinellas Park, Florida

  • Contains 5 Component(s), Includes Credits

    CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: In this session, you'll learn how to: • Review the latest life expectancy data for the US population by race/ethnicity. • Examine the historical events that impacted health disparities by race/ethnicity in the US including segregation, redlining, and mistrust. • Review clinical interventions that can lower a variety of risks for African America

    CME Credit Available:

    This activity offers .75 1A AOA 

    Note: ACOI reports credits to the AOA after the end of each quarter.

    Learning Objectives: 

    In this session, you'll learn how to:  

    • Review the latest life expectancy data for the US population by race/ethnicity.
    • Examine the historical events that impacted health disparities by race/ethnicity in the US including segregation, redlining, and mistrust.
    • Review clinical interventions that can lower a variety of risks for African Americans

    Conflict of Interest Disclosures: 

    ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Dr. Hall, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

    Release & Review Date: 

    This activity is valid from May 13, 2023, until May 13, 2026.

    Gregory Hall, MD

    Founder & Board Chairman

    National Institute for African American Health

    Founder & Board Chairman, National Institute for African American Health
    Board President, Cuyahoga County Board of Health
    Associate Professor of Internal Medicine, Northeast Ohio Medical University
    Associate Professor of Integrative Medical Sciences, Northeast Ohio Richmond Heights, Ohio